Buscar resultados de ensayos clínicos

Patrocinado por

Lymphoma, B-Cell, Marginal Zone - 24 Studies Found

Estado Estudiar
Recruiting Nombre del estudio: Marginal Zone Lymphoma Cohort in Korea
Condición: Lymphoma, B-Cell, Marginal Zone
Fecha: 2016-04-04
Intervenciones: Other: Rituximab Cohort observation study
Recruiting Nombre del estudio: Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Condición: Lymphoma, B-Cell, Marginal Zone
Fecha: 2017-03-23
Intervenciones: Drug: Ibrutinib 560mg administered orally once daily.
Completed Nombre del estudio: Endomicroscopy and Gastric MALT-lymphoma
Condición: MALT-lymphoma
Fecha: 2012-01-08
Intervenciones:
  • Procedure: Confocal laser endomicroscopy

Recruiting Nombre del estudio: Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Condición: Marginal Zone B-cell Lymphoma
Fecha: 2015-04-05
Intervenciones: Drug: bendamustine plus rituximab Bendamustine 90mg/m2 IV on days 1-2 up to 6th cycle Rituximab 375mg/m2
Active, not recruiting Nombre del estudio: Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma
Condición: MALT Lymphoma
Fecha: 2013-03-06
Intervenciones:
  • Drug: Chlorambucil
  • Drug: Rituximab i.v.
Recruiting Nombre del estudio: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma
Condición: Mucosa-Associated Lymphoid Tissue Lymphoma
Fecha: 2016-12-01
Not yet recruiting Nombre del estudio: A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
Condición:
  • Relapsed Marginal Zone Lymphoma
  • Refractory MALT Lymphoma
    Fecha: 2005-09-13
    Intervenciones: Other: Omeprazole, Amoxicillin, Clarithromycin Omeprazole20 mg,Clarithromycin500 mg b.i.d.,Day 1-14 plus
Completed Nombre del estudio: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Condición: Marginal Zone Lymphoma
Fecha: 2007-03-27
Intervenciones:
  • Drug: Rituximab IV Infusion of
Active, not recruiting Nombre del estudio: Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
Condición: Non-gastric Marginal Zone Lymphoma
Fecha: 2006-09-14
Intervenciones: Radiation: Involved Field Radiotherapy The prescribed dose
Next >>>